Type 1 and type 2 diabetes equally stressful for young adults 2 December 2014 Young adults with type 2 diabetes experience similar anxiety symptoms and levels of depression as young adults with type 1 diabetes, a study released during Mental Health Week indicated. The study, published in the Diabetic Medicine Journal, was carried out by The Australian Centre for Behavioural Research in Diabetes in partnership with Deakin University and Diabetes Australia – Vic. “The continued rise in number of people diagnosed with type 2 diabetes at a young age prompts the need to consider the different kinds of psychological issues that may surface and ways to ensure access to the right kind of support is provided,†said Diabetes NSW Head of Health and Education Services Kristen Hazelwood. “There are currently 32,000 Australians living with type 2 diabetes in the 21-39 year age range and with public perception of type 2 remaining very negative, the stigma associated with a type 2 diagnosis is a serious trigger for depression and anxiety,†Ms Hazelwood added. Lead researcher and Research Fellow at Deakin University’s School of Psychology, Dr Jessica Browne said that people often perceive type 1 diabetes to be more serious and more demanding than type 2 diabetes. “However, “the results of our study show that young adults with type 2 diabetes are as depressed and anxious as age-matched adults with type 1 diabetes,†suggesting that “in terms of their mental health, young adults with type 2 diabetes are more similar to young adults with type 1 diabetes than to older adults with type 2 diabetes.†For the full release see here
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
News 27 May 2026 Important recall: Selected Omnipod® 5 and Omnipod DASH® Pods Insulet has issued a critical recall affecting specific lots of Omnipod 5 and Omnipod DASH Pods after identifying a manufacturing... Continue Reading